Adults:
Cefepime-AFT is indicated in the treatment of the infections listed below when caused by susceptible bacteria.
Lower respiratory tract infections, including pneumonia and bronchitis.
Urinary tract infections, both complicated, including pyelonephritis, and uncomplicated infections.
Skin and skin structure infections.
Intra-abdominal infections, including peritonitis and biliary tract infections.
Gynaecological infections.
Septicaemia
Empiric treatment in febrile neutropenic patients (See PRECAUTIONS)
Cefepime-AFT is also indicated for surgical prophylaxis in patients undergoing intra-abdominal surgery. In this indication it is essential that metronidazole also be administered.
Paediatrics:
Cefepime-AFT is indicated in paediatric patients over 2 months of age for the treatment of the infections listed below when caused by susceptible bacteria:
Pneumonia
Urinary tract infections, both complicated, including pyelonephritis, and uncomplicated infections
Skin and skin structure infections
Septicaemia
Empiric treatment in febrile neutropenic patients (See PRECAUTIONS)
Culture and susceptibility studies should be performed when appropriate to determine susceptibility of the causative organism(s) to cefepime. Empiric therapy with Cefepime-AFT may be instituted before results of susceptibility studies are known; however, once these results become available, the antibiotic treatment should be adjusted accordingly.
Because of its broad spectrum of bactericidal activity against gram-positive and gram-negative bacteria, Cefepime-AFT can be used appropriately as monotherapy prior to identification of the causative organisms(s). In the treatment of febrile neutropenia, consideration should be given to the need for other antibiotics in combination with Cefepime-AFT. In patients who are at risk of mixed aerobic-anaerobic infection, including infections in which Bacterioides fragilis may be present, concurrent initial therapy with an anti-anaerobic agent is recommended before the causative organism(s) is known.
How to take it
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.
The way to take this medicine: Intramuscular
Store below 25 degrees Celsius
Store in Original Container
Protect from Light
Shelf lifetime is 2 Years.
Always read the label. If symptoms persist see your healthcare professional.
Visual appearance
White to off white powder
Do I need a prescription?
This medicine is available from a pharmacist and requires a prescription. It is
Schedule 4 : Prescription Only Medicine.
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Adults:
Cefepime-AFT is indicated in the treatment of the infections listed below when caused by susceptible bacteria.
Lower respiratory tract infections, including pneumonia and bronchitis.
Urinary tract infections, both complicated, including pyelonephritis, and uncomplicated infections.
Skin and skin structure infections.
Intra-abdominal infections, including peritonitis and biliary tract infections.
Gynaecological infections.
Septicaemia
Empiric treatment in febrile neutropenic patients (See PRECAUTIONS)
Cefepime-AFT is also indicated for surgical prophylaxis in patients undergoing intra-abdominal surgery. In this indication it is essential that metronidazole also be administered.
Paediatrics:
Cefepime-AFT is indicated in paediatric patients over 2 months of age for the treatment of the infections listed below when caused by susceptible bacteria:
Pneumonia
Urinary tract infections, both complicated, including pyelonephritis, and uncomplicated infections
Skin and skin structure infections
Septicaemia
Empiric treatment in febrile neutropenic patients (See PRECAUTIONS)
Culture and susceptibility studies should be performed when appropriate to determine susceptibility of the causative organism(s) to cefepime. Empiric therapy with Cefepime-AFT may be instituted before results of susceptibility studies are known; however, once these results become available, the antibiotic treatment should be adjusted accordingly.
Because of its broad spectrum of bactericidal activity against gram-positive and gram-negative bacteria, Cefepime-AFT can be used appropriately as monotherapy prior to identification of the causative organisms(s). In the treatment of febrile neutropenia, consideration should be given to the need for other antibiotics in combination with Cefepime-AFT. In patients who are at risk of mixed aerobic-anaerobic infection, including infections in which Bacterioides fragilis may be present, concurrent initial therapy with an anti-anaerobic agent is recommended before the causative organism(s) is known.
How to take it
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.
The way to take this medicine: Intramuscular
Store below 25 degrees Celsius
Store in Original Container
Protect from Light
Shelf lifetime is 2 Years.
Always read the label. If symptoms persist see your healthcare professional.
Visual appearance
White to off white powder
Do I need a prescription?
This medicine is available from a pharmacist and requires a prescription. It is
Schedule 4 : Prescription Only Medicine.
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Adults:
Cefepime-AFT is indicated in the treatment of the infections listed below when caused by susceptible bacteria.
Lower respiratory tract infections, including pneumonia and bronchitis.
Urinary tract infections, both complicated, including pyelonephritis, and uncomplicated infections.
Skin and skin structure infections.
Intra-abdominal infections, including peritonitis and biliary tract infections.
Gynaecological infections.
Septicaemia
Empiric treatment in febrile neutropenic patients (See PRECAUTIONS)
Cefepime-AFT is also indicated for surgical prophylaxis in patients undergoing intra-abdominal surgery. In this indication it is essential that metronidazole also be administered.
Paediatrics:
Cefepime-AFT is indicated in paediatric patients over 2 months of age for the treatment of the infections listed below when caused by susceptible bacteria:
Pneumonia
Urinary tract infections, both complicated, including pyelonephritis, and uncomplicated infections
Skin and skin structure infections
Septicaemia
Empiric treatment in febrile neutropenic patients (See PRECAUTIONS)
Culture and susceptibility studies should be performed when appropriate to determine susceptibility of the causative organism(s) to cefepime. Empiric therapy with Cefepime-AFT may be instituted before results of susceptibility studies are known; however, once these results become available, the antibiotic treatment should be adjusted accordingly.
Because of its broad spectrum of bactericidal activity against gram-positive and gram-negative bacteria, Cefepime-AFT can be used appropriately as monotherapy prior to identification of the causative organisms(s). In the treatment of febrile neutropenia, consideration should be given to the need for other antibiotics in combination with Cefepime-AFT. In patients who are at risk of mixed aerobic-anaerobic infection, including infections in which Bacterioides fragilis may be present, concurrent initial therapy with an anti-anaerobic agent is recommended before the causative organism(s) is known.
How to take it
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.
The way to take this medicine: Intramuscular
Store below 25 degrees Celsius
Store in Original Container
Protect from Light
Shelf lifetime is 2 Years.
Always read the label. If symptoms persist see your healthcare professional.
Visual appearance
White to off white powder
Do I need a prescription?
This medicine is available from a pharmacist and requires a prescription. It is
Schedule 4 : Prescription Only Medicine.
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Adults:
Cefepime-AFT is indicated in the treatment of the infections listed below when caused by susceptible bacteria.
Lower respiratory tract infections, including pneumonia and bronchitis.
Urinary tract infections, both complicated, including pyelonephritis, and uncomplicated infections.
Skin and skin structure infections.
Intra-abdominal infections, including peritonitis and biliary tract infections.
Gynaecological infections.
Septicaemia
Empiric treatment in febrile neutropenic patients (See PRECAUTIONS)
Cefepime-AFT is also indicated for surgical prophylaxis in patients undergoing intra-abdominal surgery. In this indication it is essential that metronidazole also be administered.
Paediatrics:
Cefepime-AFT is indicated in paediatric patients over 2 months of age for the treatment of the infections listed below when caused by susceptible bacteria:
Pneumonia
Urinary tract infections, both complicated, including pyelonephritis, and uncomplicated infections
Skin and skin structure infections
Septicaemia
Empiric treatment in febrile neutropenic patients (See PRECAUTIONS)
Culture and susceptibility studies should be performed when appropriate to determine susceptibility of the causative organism(s) to cefepime. Empiric therapy with Cefepime-AFT may be instituted before results of susceptibility studies are known; however, once these results become available, the antibiotic treatment should be adjusted accordingly.
Because of its broad spectrum of bactericidal activity against gram-positive and gram-negative bacteria, Cefepime-AFT can be used appropriately as monotherapy prior to identification of the causative organisms(s). In the treatment of febrile neutropenia, consideration should be given to the need for other antibiotics in combination with Cefepime-AFT. In patients who are at risk of mixed aerobic-anaerobic infection, including infections in which Bacterioides fragilis may be present, concurrent initial therapy with an anti-anaerobic agent is recommended before the causative organism(s) is known.
How to take it
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.
The way to take this medicine: Intramuscular
Store below 25 degrees Celsius
Store in Original Container
Protect from Light
Shelf lifetime is 2 Years.
Always read the label. If symptoms persist see your healthcare professional.
Visual appearance
White to off white powder
Do I need a prescription?
This medicine is available from a pharmacist and requires a prescription. It is
Schedule 4 : Prescription Only Medicine.
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Adults:
Cefepime-AFT is indicated in the treatment of the infections listed below when caused by susceptible bacteria.
Lower respiratory tract infections, including pneumonia and bronchitis.
Urinary tract infections, both complicated, including pyelonephritis, and uncomplicated infections.
Skin and skin structure infections.
Intra-abdominal infections, including peritonitis and biliary tract infections.
Gynaecological infections.
Septicaemia
Empiric treatment in febrile neutropenic patients (See PRECAUTIONS)
Cefepime-AFT is also indicated for surgical prophylaxis in patients undergoing intra-abdominal surgery. In this indication it is essential that metronidazole also be administered.
Paediatrics:
Cefepime-AFT is indicated in paediatric patients over 2 months of age for the treatment of the infections listed below when caused by susceptible bacteria:
Pneumonia
Urinary tract infections, both complicated, including pyelonephritis, and uncomplicated infections
Skin and skin structure infections
Septicaemia
Empiric treatment in febrile neutropenic patients (See PRECAUTIONS)
Culture and susceptibility studies should be performed when appropriate to determine susceptibility of the causative organism(s) to cefepime. Empiric therapy with Cefepime-AFT may be instituted before results of susceptibility studies are known; however, once these results become available, the antibiotic treatment should be adjusted accordingly.
Because of its broad spectrum of bactericidal activity against gram-positive and gram-negative bacteria, Cefepime-AFT can be used appropriately as monotherapy prior to identification of the causative organisms(s). In the treatment of febrile neutropenia, consideration should be given to the need for other antibiotics in combination with Cefepime-AFT. In patients who are at risk of mixed aerobic-anaerobic infection, including infections in which Bacterioides fragilis may be present, concurrent initial therapy with an anti-anaerobic agent is recommended before the causative organism(s) is known.
How to take it
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.
The way to take this medicine: Intramuscular
Store below 25 degrees Celsius
Store in Original Container
Protect from Light
Shelf lifetime is 2 Years.
Always read the label. If symptoms persist see your healthcare professional.
Visual appearance
White to off white powder
Do I need a prescription?
This medicine is available from a pharmacist and requires a prescription. It is
Schedule 4 : Prescription Only Medicine.
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
